Market closed

Medpace/$MEDP

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Medpace

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Ticker

$MEDP
Sector
Health Care
Trading on
NASDAQ

Industry

Life Sciences Tools & Services
Headquarters
Cincinnati, United States

Employees

5,900
Website
www.medpace.com

Medpace Metrics

BasicAdvanced
$11B
30.82
$11.42
1.35
-

$11B

1.35

$459.77

$277.72

230K

0.992

0.93

14.553

17.232

14.31%

54.08%

30.817

5.252

12.38

59.23

20.306

16.24%

33.84%

23.72%

33.23%

What the Analysts think about Medpace

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Medpace stock.

Medpace Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Medpace Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Medpace News

AllArticlesVideos
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations

Accesswire·13 hours ago
Medpace Holdings Inc Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Medpace Holdings Inc Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire·1 day ago
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations

Accesswire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MEDP

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Medpace stock?

Medpace (MEDP) has a market cap of $11B as of January 15, 2025.

What is the P/E ratio for Medpace stock?

The price to earnings (P/E) ratio for Medpace (MEDP) stock is 30.82 as of January 15, 2025.

Does Medpace stock pay dividends?

No, Medpace (MEDP) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Medpace dividend payment date?

Medpace (MEDP) stock does not pay dividends to its shareholders.

What is the beta indicator for Medpace?

Medpace (MEDP) has a beta rating of 1.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.